Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2021 Aug 19;56(10):2615. doi: 10.1038/s41409-021-01424-5

Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study

Andre Manfred Willasch 1,, Christina Peters 2, Petr Sedláček 3, Jean-Hugues Dalle 4, Vassiliki Kitra-Roussou 5, Akif Yesilipek 6, Jacek Wachowiak 7, Arjan Lankester 8, Arcangelo Prete 9, Amir Ali Hamidieh 10, Marianne Ifversen 11, Jochen Buechner 12, Gergely Kriván 13, Rose-Marie Hamladji 14, Cristina Diaz-de-Heredia 15, Elena Skorobogatova 16, Gérard Michel 17, Franco Locatelli 18,19, Alice Bertaina 18,19,20, Paul Veys 21, Sophie Dupont 22, Reuven Or 23, Tayfun Güngör 24, Olga Aleinikova 25, Sabina Sufliarska 26, Mikael Sundin 27, Jelena Rascon 28, Ain Kaare 29, Damir Nemet 30, Franca Fagioli 31, Thomas Erich Klingebiel 1, Jan Styczynski 32, Marc Bierings 33, Kálmán Nagy 34, Manuel Abecasis 35, Boris Afanasyev 36, Marc Ansari 37, Kim Vettenranta 38, Amal Alseraihy 39, Alicja Chybicka 40, Stephen Robinson 41, Yves Bertrand 42, Alphan Kupesiz 43, Ardeshir Ghavamzadeh 44, Antonio Campos 45, Herbert Pichler 2, Arnaud Dalissier 46, Myriam Labopin 47, Selim Corbacioglu 48, Adriana Balduzzi 49, Jacques-Emmanuel Galimard 46, Peter Bader 1; on behalf of the EBMT Paediatric Diseases Working Party
PMCID: PMC8486667  PMID: 34413474

Correction to: Bone Marrow Transplantation 10.1038/s41409-020-0854-0, published online 17 March 2020

The article “Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study,” written by Andre Manfred Willasch, Christina Peters, Petr Sedláček, Jean-Hugues Dalle, Vassiliki Kitra-Roussou, Akif Yesilipek, Jacek Wachowiak, Arjan Lankester, Arcangelo Prete, Amir Ali Hamidieh, Marianne Ifversen, Jochen Buechner, Gergely Kriván, Rose-Marie Hamladji, Cristina Diaz-de-Heredia, Elena Skorobogatova, Gérard Michel, Franco Locatelli, Alice Bertaina, Paul Veys, Sophie Dupont, Reuven Or, Tayfun Güngör, Olga Aleinikova, Sabina Sufliarska, Mikael Sundin, Jelena Rascon, Ain Kaare, Damir Nemet, Franca Fagioli, Thomas Erich Klingebiel, Jan Styczynski, Marc Bierings, Kálmán Nagy, Manuel Abecasis, Boris Afanasyev, Marc Ansari, Kim Vettenranta, Amal Alseraihy, Alicja Chybicka, Stephen Robinson, Yves Bertrand, Alphan Kupesiz, Ardeshir Ghavamzadeh, Antonio Campos, Herbert Pichler, Arnaud Dalissier, Myriam Labopin, Selim Corbacioglu, Adriana Balduzzi, Jacques-Emmanuel Galimard, Peter Bader, on behalf of the EBMT Paediatric Diseases Working Party, was originally published online first without Open Access. After publication in volume 55, issue 8, page 1540–1551, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2020 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 InternationalS License, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0. Open access funding was enabled and organized by Projekt DEAL.


Articles from Bone Marrow Transplantation are provided here courtesy of Nature Publishing Group

RESOURCES